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Coxiella burnetii, the etiological agent of Q fever, has two phase variants. Phase I has a complete lipopoly-
saccharide (LPS), is highly virulent, and causes Q fever in humans and pathology in experimental animals.
Phase II lacks an LPS O side chain, is avirulent, and does not grow well in immunocompetent animals. To
understand the pathogenicity of Q fever, we investigated the roles of immune components in animals infected
with Nine Mile phase I (NM I) or Nine Mile phase II (NM II) bacteria. Immunodeficient mice, including SCID
mice (deficient in T and B cells), SCIDbg mice (deficient in T, B, and NK cells), nude mice (deficient in T cells),
muMT mice (deficient in B cells), bg mice (deficient in NK cells), mice deficient in tumor necrosis factor alpha
(TNF-/mice), and mice deficient in gamma interferon (IFN-/mice), were compared for their responses
to infection. SCID, SCIDbg, nude, and IFN-/mice showed high susceptibility to NM I, and TNF-/mice
showed modest susceptibility. Disease caused by NM I in SCID, SCIDbg, and nude mice progressed slowly,
while disease in IFN-/ and TNF-/ mice advanced rapidly. B- and NK-cell deficiencies did not enhance
clinical disease development or alter bacterial clearance but did increase the severity of histopathological
changes, particularly in the absence of B cells. Mice infected with NM II showed no apparent clinical disease,
but T-cell-deficient mice had histopathological changes. These results suggest that T cells are critical for
clearance of C. burnetii, either NM I or NM II, that IFN- and TNF- are essential for the early control of
infection, and that B cells are important for the prevention of tissue damage.
Coxiella burnetii is an obligate intracellular bacterium and
the etiological agent of Q fever. Q fever is a worldwide zoo-
nosis with a broad host range including humans, wild and
domestic animals, birds, and arthropods (32). Naturally in-
fected animals rarely demonstrate disease except for reproduc-
tive disorders, including late-term abortion (4). The disease in
humans can present in either an acute or chronic form (27).
Acute Q fever is mainly a flu-like syndrome that is primarily
self-limiting and can be readily treated with antibiotics when
the appropriate diagnosis is made (30). The chronic form fre-
quently manifests as endocarditis, a serious and difficult-to-
treat outcome of infection (15).
Immunocompetent laboratory animals, such as guinea pigs
and mice, are routinely used as animal models for Q fever (33,
34). Guinea pigs are sensitive to the infection, show a fever
response and pathology, and have a higher mortality rate than
mice (24, 28, 33). Mice do not generally manifest significant
clinical disease, but some strains are more sensitive than oth-
ers, as shown by differences in their mortality rates. Among this
range of differences, the A/J mouse is considered a sensitive
strain (high mortality) and the C57BL/6J mouse is considered
a resistant strain (low mortality) (33, 34). Nude and severe
combined immunodeficient mice (SCID; T and B cell defi-
cient) are highly sensitive to the infection (2, 26). In addition,
it has been shown that immunosuppressive treatments can
alter the sensitivity of mice to infection (3, 25). The observa-
tion that C. burnetii phase I infection causes lethal disease in
SCID mice supports the notion that acquired immunity is es-
sential for the host defense against the infection (2). However,
the immune components that are required for the successful
control of infection have not been defined.
Macrophages are the major target cells during C. burnetii
infection. Cytokines that regulate macrophage bactericidal ac-
tivity, such as gamma interferon (IFN-) and tumor necrosis
factor alpha (TNF-), have been shown to be important factors
in infection control. Indeed, failure to produce IFN- has been
reported in chronic Q fever patients (30), and there is one case
report of effective IFN- treatment of a Q fever patient (29). In
vitro studies showed effective killing of intracellular C. burnetii
with a supplement of IFN- and TNF- (6, 20).
The phase variation phenotype parallels the smooth-to-
rough lipopolysaccharide (LPS) transition of many gram-neg-
ative enterobacteria (1). Upon serial in vitro passage of viru-
lent C. burnetii, avirulent LPS phase variants outgrow virulent
organisms, allowing a population shift in culture (4). Phase I is
highly virulent, replicates in immunocompetent animals, and
causes Q fever in humans and pathology in experimental ani-
mals. Phase II is an avirulent variant that does not replicate in
immunocompetent animals (28). Uptake of phase I bacteria by
human monocytes is mediated by v3 integrin, resulting in
interference with CR3 activation and a reduction in phagocytic
activity, whereas uptake of phase II bacteria is mediated by
* Corresponding author. Mailing address: Department of Microbial
and Molecular Pathogenesis, Texas A&M Health Science Center, 407
Reynolds Bldg., College Station, TX 77843-1114. Phone: (979) 862-
1684. Fax: (979) 845-3479. E-mail: jsamuel@tamhsc.edu.
 Published ahead of print on 16 April 2007.
3245
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
both v3 integrin and CR3 and does not affect CR3 activation
(8). In contrast to what occurs in in vivo conditions, phase II
bacteria can replicate in an in vitro culture lacking host immu-
nity (28). Nine Mile phase I (NM I) (strain RSA 493) organ-
isms encode a complete LPS with the O side chain, while Nine
Mile phase II (NM II) (strain RSA 439) organisms do not
express the O side chain or several terminal sugar residues
because of a major deletion of genes involved in LPS biosyn-
thesis (19). Based on the difference in virulence of these phase
variants, phase I bacteria require biosafety level 3 (BL3) con-
tainment, while phase II bacteria can be cultured under BL2
conditions. However, the factors that are responsible for the
difference in virulence between phase I and phase II have not
been clearly demonstrated.
In this study, we investigated the in vivo role of immune
system components (T, B, and NK cells, IFN-, and TNF-) in
NM I and NM II infections in mice. Clinical signs, bacteremia,
splenomegaly, quantification of bacteria in the spleen, histo-
pathology, and immunohistochemistry were used as indicators
to evaluate the pathogenicity of NM I and NM II. This study
provides novel information for understanding the mechanisms
of host defense against C. burnetii infection.
MATERIALS AND METHODS
Bacteria. Two cloned isolates, C. burnetii RSA 493 (NM I) and C. burnetii RSA
439 (NM II) were used. NM I was cultured in embryonated chicken eggs, and
NM II was cultured in L929 cells; both were purified by gradient centrifugation
and stored at 80°C until use. Enumeration of bacteria was performed by
quantitative PCR as described below.
Animals. Five- to 6-week-old female mice were purchased from Taconic (Ger-
mantown, NY) or Jackson Laboratory (Bar Harbor, ME). The various mouse
strains and their relevant immunological characteristics are shown in Table 1.
Two wild-type (wt) mouse strains (CB17 and B6) were used as controls appro-
priately for each experiment. Mice were housed under sterile conditions in BL3
facilities. All animal experiments were performed under an animal protocol
approved by the University Laboratory Animal Care Committee of Texas A&M
University.
Experimental infection in mice. Four mice per group were infected intraperi-
toneally with a low dose (102 genome copies/mouse) or high dose (105 genome
copies/mouse) of C. burnetii. Phosphate-buffered saline (PBS) was used as a
sham infection control. Apparent clinical signs were observed daily, and body
weights were recorded at 0, 7, 14, 21, and 28 days postinfection (DPI). Body
weight changes were expressed as the body weight index. The body weight
index is the relative body weight on a day divided by the relative body weight
of sham-infected mice on the same day; the relative body weight is the body
weight on each day divided by the body weight at zero time. Blood was
collected from the lateral saphenous vein at 7, 14, and 21 DPI and by cardiac
puncture at 28 DPI after euthanasia. Bacteremia was determined by detecting
C. burnetii DNA in 10 l of whole blood. At necropsy, spleens were weighed,
small pieces were collected for DNA extraction, and the DNA was used for
C. burnetii gene detection by quantitative PCR to confirm growth of the
bacteria. Hearts, lungs, livers, and spleens were fixed in 10% formalin–PBS
for histopathology.
Quantitative PCR. Purified bacteria or blood was directly mixed with lysis
buffer. Small pieces of spleen were weighed and homogenized with lysis buffer,
and parts of the homogenates were used for DNA extraction. DNA extraction
and real-time PCR were performed as described previously (7). Briefly, samples
were digested with proteinase K, followed by DNA extraction using a High Pure
PCR template preparation kit (Roche Molecular Biochemicals, Indianapolis,
IN). DNA was used as a template for quantifying the number of C. burnetii com1
gene copies. The bacterial genome copy number per whole spleen was extrapo-
lated from the copy number of each PCR and the weights of spleen pieces and
whole spleens.
FIG. 1. Body weight changes of mice infected with the low dose of NM I or NM II. (A) wt (CB17) mice; (B) SCID mice; (C) SCIDbg mice.
Data for SCIDbg mice infected with the low dose of NM I at 28 DPI are not available because of death of the mice. The results (means standard
deviations) are expressed as the body weight index. One asterisk indicates that the P value is 0.05 and two asterisks indicate that the P value is
0.001 for comparisons of infected mice with PBS-inoculated control mice.
TABLE 1. Immunological characteristics of mouse strains used
Designation Defect Strain Source
SCID T and B cells C.B-Igh-1b/IcrTac-Prkdcscid Taconic
SCIDbg T, B, and NK cells C.B-Igh-1bGbmsTac-Prkdcscid-LystbgN7 Taconic
Nude T cells B6.Cg-Foxn1nu/J Jackson
muMT B cells B6.129S2-Igh-6tm1Cgn/J Jackson
bg NK cells C57BL/6J-Lystbg-J/J Jackson
IFN-/ IFN- B6.129S7-Ifng tm1Ts/J Jackson
TNF-/ TNF- B6.129S6-Tnf tm1Gkl/J Jackson
CB17 None (wt) C.B-Igh-1b/IcrTac Taconic
B6 None (wt) C57BL/6J Jackson
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Serology. Serum samples were diluted from 1:16 to 1:2,048 by twofold dilution.
C. burnetii phase I and II specific antibody titers were measured by an indirect
immunofluorescent assay using whole-cell antigen fixed in 24-spot slides and goat
Alexafluor 488-labeled anti-mouse immunoglobulin G(HL) [IgG(HL)] anti-
body (Molecular Probes, Carlsbad, CA).
Histopathology. Formalin-fixed tissues were mounted in paraffin, sliced, and
stained with hematoxylin and eosin (HE). The degree of inflammation was
scored as follows: 0, no appreciable inflammatory changes; 1, mild inflammation,
consisting of a slight increase in the numbers of lymphocytes and macrophages;
2, moderate inflammation, characterized by scattered accumulations of lympho-
cytes and macrophages, occasionally accompanied by mild necrosis; 3, marked
inflammation, consisting of locally extensive macrophage and lymphocyte accu-
mulations with hyperemia and hemorrhage and scattered mild to moderate
necrosis; and 4, severe inflammation, characterized by dense accumulations of
macrophages and lymphocytes with hyperemia and hemorrhage and moderate to
severe necrosis. Extramedullary hematopoiesis (EMH) was defined as random in
distribution, containing erythrocytic series cells and including megakaryocytes,
which can be distinguished from inflammation that is accompanied by hyper-
emia, hemorrhage, and necrosis and does not include megakaryocytes. Immu-
nohistochemistry (IHC) analysis was performed with rabbit anti-C. burnetii phase
I serum and a VECTASTAIN ABC kit (Vector Laboratories, Burlingame, CA)
used according to the manufacturer’s protocol. The degree of C. burnetii antigen
distribution was scored as follows: 0, none; 1, mild, rare immunopositive cells
(less than 10 positive cells per tissue); 2, moderate, a few immunopositive cells
(more than 10 positive cells); 3, marked, several, and/or multifocal distribution of
immunopositive cells in each field; and 4, severe, diffuse distribution of immu-
nopositive cells in each field.
Statistics. Results expressed as means  standard deviations were compared
with Student’s t test. Differences were considered significant at a P value of
0.05.
RESULTS
Low-dose infection with phase I and II C. burnetii in multi-
ple-immune-component-deficient mice. To evaluate the in vivo
growth and virulence of NM I and NM II bacteria in mice
lacking acquired cell-mediated immunity, we first compared
low-dose infections in mice with deficiencies in multiple im-
mune system components. SCID and SCIDbg mice infected
with the low dose of NM I showed severe persistent illness.
Animals exhibited ruffled fur, a hunched posture, and severe
weight loss (Fig. 1). SCIDbg mice died at 27.8  0.5 DPI.
Bacteremia was detected in both SCID and SCIDbg mice at 14,
21, and 28 DPI (data not shown). wt mice infected with the low
dose of NM I exhibited only transient ruffled fur, and no
bacteremia was detected. Splenomegaly was extremely severe
in SCIDbg and SCID mice (the splenomegaly in SCID mice
was more severe than that in SCIDbg mice [P  0.05]) but was
mild in wt mice (Fig. 2A). White necrotic foci were found in
the livers of SCID and SCIDbg mice. The bacterial loads in the
spleens were similar in SCID and SCIDbg mice, and they were
higher than those in wt mice (Fig. 2B). Coxiella DNA was
undetectable in PBS control groups. Histopathologically,
SCIDbg and SCID mice had moderate to severe cellular in-
flammation (Table 2). Distribution of C. burnetii antigen, de-
tected as brown granules by IHC staining, was associated with
cellular infiltration (Fig. 3). The heart had accumulations of
macrophages in subepicardial, valvular, and subendocardial
regions, and there were scattered macrophages within the myo-
cardium, but not all sites were necessarily infiltrated in an
individual specimen (Fig. 3B to E). Subepicardial mineraliza-
tion was occasionally noted. Lungs had multifocal perivascular
accumulations of macrophages, which were milder in SCID
mice than in SCIDbg mice, and scattered to diffuse areas of
interstitial neutrophil accumulation (Fig. 3G to J). Livers had
marked multifocal to extensive accumulations of macrophages
and multifocal random to marked diffuse neutrophil accumu-
lation (Fig. 3L to O). Additionally, SCIDbg mice had multifo-
cal hepatocellular coagulative necrosis. Spleens had marked
FIG. 2. Spleens of mice infected with the low dose of NM I or NM
II: splenomegaly (A) and bacterial genome numbers (B) in the spleen
at 28 DPI. The results (means  standard deviations) are expressed as
the percentage of spleen weight compared with the body weight
(A) and the number of C. burnetii genomes in the whole spleen (B).
One asterisk indicates that the P value is 0.05, and two asterisks
indicate that the P value is 0.001. Double dagger, not detected.
TABLE 2. Degree of inflammation and C. burnetii antigen distribution in mice infected with the low dose of NM I or NM II at 28 DPI
Mice
Mean inflammation score (mean antigen distribution score) witha:
NM I infection NM II infection PBS (heart, lung,
liver, and spleen)Heart Lung Liver Spleen Heart Lung Liver Spleen
SCIDbg 2.6b (3.3b) 2.3b (3.0b) 3.8b (3.7b) 4.0b (4.0b) 0.3 (0.0) 0.0 (0.0) 1.8b (0.0) 0.0 (0.0) 0.0 (0.0)
SCID 2.6b (2.3b) 3.8b (2.7b) 3.0b (3.7b) 4.0b (4.0b) 0.0 (0.0) 0.0 (0.0) 1.3b (0.0) 0.0 (0.0) 0.0 (0.0)
wt (CB17) 0.0 (0.0) 0.0 (0.0) 0.0 (0.3) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
a 0, none; 1, mild; 2, moderate; 3, marked; 4, severe.
b P  0.05 for a comparison with the wt group with the same infection.
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multifocal diffuse accumulations of macrophages and moder-
ate to marked diffuse neutrophil accumulations (Fig. 3Q to T).
Extensive infiltration of inflammatory cells in livers and spleens
obscured or distorted the normal tissue architecture. wt mice
infected with the low dose of NM I had mild mineralization in
the heart and mild multifocal cellular coagulation in the liver.
In contrast to NM I infection, no mice infected with NM II
showed clinical illness or bacteremia. However, SCID and
SCIDbg mice infected with NM II had splenomegaly (Fig. 2A).
Coxiella DNA in the spleen was detected in both SCID and
SCIDbg mice but not in wt mice (Fig. 2B). SCID and SCIDbg
mice infected with NM II had mild histopathological changes
in the heart, liver, and spleen but not in the lungs (Table 2). In
the heart, mild multifocal subendocardial mineralization with
mild subjacent accumulation of mainly macrophages was ob-
served in one SCIDbg mouse, and focal or moderate locally
extensive subepicardial mineralization was observed in three of
four SCID mice and in one wt mouse. In the liver, SCIDbg
mice had multifocal, mild to moderate macrophage and neu-
trophil accumulations associated with necrotic foci and multi-
focal hepatocellular coagulative necrosis; SCID mice had ran-
dom, multifocal scattered macrophage accumulations. Spleens
of both SCIDbg and SCID mice exhibited increased or mod-
erate to marked EMH. No specific histopathological change or
C. burnetii antigen was found in wt mice infected with NM II
and in PBS groups.
These results confirmed the high susceptibility of multiple-
immune-component-deficient mice to phase I C. burnetii, as
previously reported (2), and that NK cells have an accessory
role in control of the infection through innate immunity. These
results also showed that phase II C. burnetii replicates in vivo
in the absence of acquired cell-mediated immunity, although
not as efficiently as phase I.
High-dose infection with phase II C. burnetii in multiple-
immune-component-deficient mice. Low-dose challenge with
phase II bacteria resulted in no apparent clinical illness, even
though animals were permissive for replication of NM II. To
confirm the reduced virulence of phase II bacteria, we used
high-dose infections (105 genome copies) with NM II in mul-
tiple-immune-component-deficient mice.
No animals infected with the high dose of NM II showed
clinical signs of illness, and no bacteremia was detected.
Splenomegaly was found in SCID and SCIDbg mice, and it was
more severe in SCIDbg mice (P  0.05) (Fig. 4A). SCIDbg
mice had numerous white necrotic foci in the liver. Similar
amounts of bacteria were detected in spleens of SCID and
SCIDbg mice (Fig. 4B). wt mice infected with the high dose of
NM II did not have splenomegaly or detectable bacterial DNA.
Histopathologic changes were noted in the liver (Table 3).
Examination of livers of SCID and SCIDbg mice revealed
multifocal random macrophage accumulations, and there was
occasional coagulative necrosis of hepatocytes in SCIDbg mice
(Fig. 5A and B). Livers of wt mice had focal and perivascular
inflammation consisting of macrophages and lymphocytes (Fig.
5C). Spleens had moderate EMH in all mouse strains; addi-
tionally, small discrete accumulations of macrophages were
FIG. 3. Histopathology of SCIDbg mice infected with the low dose of NM I at 28 DPI. (A to E) Heart; (F to J) lung; (K to O) liver; (P to T)
spleen. Panels A, F, K, and P show the results for control mice from the PBS group. HE staining or IHC staining (C, E, H, J, M, O, R, and T)
was used. (A to H, K to M, and P to R) Original magnification, 	100; (S and T) original magnification, 	200; (I, J, N, and O) original
magnification,	400. Severe cellular infiltrations associated with C. burnetii antigen (brown granules with IHC staining) were observed in all tissues
from infected mice. Subepicardial lesions (B and C), subendocardial lesions (D and E), and peribronchial and some perialveolar lesions (G to J)
were also observed, and extensive cellular infiltrations obscured the tissue architecture in the liver and spleen associated with diffuse antigen
distribution (L to O and Q to T).
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noted in SCID mice. Hearts of SCID and wt mice had occa-
sional mild to marked subepicardial mineralization. In lungs,
SCIDbg mice had no specific changes; SCID mice had occa-
sional focal vascular thrombosis, and wt mice had focal dense
accumulations of macrophages. No specific histopathological
change, except occasional mild to moderate subepicardial min-
eralization in the heart, or C. burnetii antigen was found in PBS
groups.
These results revealed that there was low-level virulence of
phase II C. burnetii in immunocompromised mice compared to
the avirulence in immunocompetent mice. The splenomegaly,
bacterial load in spleen, and histopathology scores for the NM
II high-dose infection were lower than those for the NM I
low-dose infection, indicating the relatively low but detectable
virulence of NM II.
High-dose infection with phase I and II C. burnetii in mice
deficient in a single immune component. To investigate the
roles of selected immune components in C. burnetii infection,
we performed high-dose infections using NM I and NM II in
several single-immune-component-deficient mice. Based on
the critical role that IFN- and TNF- play in macrophage
bactericidal activity, IFN-- and TNF--deficient mice were
used. Additionally, based on the phenotypic differences ob-
served in wt, SCID, and SCIDbg mice, we compared infections
in T-cell-, B-cell-, and NK-cell-deficient mice.
After high-dose NM I infection, only nude and IFN-/
mice showed body weight loss (Fig. 6). Mortality occurred only
in IFN-/ mice. Three of four IFN-/ mice died at 12.3
0.6 days; the surviving IFN-/ mouse lost body weight until
14 DPI but recovered by 28 DPI. Bacteremia was detected in
nude, TNF-/, and IFN-/ mice infected with the high
dose of NM I; in nude mice, bacteremia appeared after 14 DPI,
while in TNF-/ and IFN-/ mice it developed early in
infection (Table 4). Splenomegaly was found in all mouse
strains, but only nude mice had significantly more severe
splenomegaly than wt mice (Fig. 7A). Coxiella DNA was de-
tected in the spleen in all mouse strains, and the bacterial load
was significantly higher in nude, TNF-/, and IFN-/
(mortality group) mice than in wt mice (Fig. 7B). After high-
dose NM II infection, body weight loss and bacteremia were
not found in any mice, and splenomegaly and Coxiella DNA
detection occurred only in nude mice (Fig. 6 and 7).
Antibody detection showed high titers of anti-phase II anti-
body and moderate titers of anti-phase I antibody in wt, bg,
TNF-/, and IFN-/ mice infected with NM I (Table 5).
bg, TNF-/, IFN-/, and wt mice infected with NM I had
higher IgG titers than mice infected with NM II. Nude mice,
however, had no detectable IgG titer after NM I infection, but
IgG was detected following NM II infection.
Histopathological changes, mainly macrophage accumula-
tions, were found in all mice infected with NM I (Table 3).
IFN-/ mice had the most substantial systemic inflammatory
FIG. 4. Spleens of mice infected with the high dose of NM II:
splenomegaly (A) and bacterial genome numbers (B) in the spleen at
28 DPI. The results (means  standard deviations) are expressed as
the percentage of spleen weight based on the body weight (A) and the
number of C. burnetii genomes in the whole spleen (B). An asterisk
indicates that the P value is 0.05. SCID and SCIDbg mice were
significantly different from PBS-inoculated groups (P  0.05) for
splenomegaly (A). Double dagger, not detected.
TABLE 3. Degree of inflammation and C. burnetii antigen distribution in mice infected with the high dose of NM I or NM II at 28 DPI
Mice
Mean inflammation score (mean antigen distribution score) witha:
NM I infection NM II infection PBS (heart, lung,
liver, and spleen)Heart Lung Liver Spleen Heart Lung Liver Spleen
SCIDbg 0.0 (0.0) 0.0 (0.0) 2.8b (1.0b) 0.0 (2.0b) 0.0 (0.0)
SCID 0.0 (0.0) 0.0 (0.0) 2.0b (0.8b) 1.0b (2.0b) 0.0 (0.0)
wt (CB17) 0.0 (0.0) 0.3 (0.0) 0.8 (0.0) 0.0 (0.0) 0.0 (0.0)
Nude 0.0 (1.5b) 0.0 (1.9b) 1.5 (3.5b) 0.0b (4.0)b 0.0 (0.0) 1.0b (0.0) 1.0 (0.3) 1.0b (0.7) 0.0 (0.0)
muMT 1.3 (0.0) 1.3b (0.0) 3.0b (0.0) 3.3b (0.0) 0.1 (0.0) 0.3 (0.0) 2.3b (0.0) 0.0 (0.0) 0.0 (0.0)
bg 0.9 (0.0) 0.1 (0.0) 2.8b (0.0) 3.0 (1.7) 0.0 (0.0) 0.1 (0.0) 1.0 (0.0) 0.0 (0.0) 0.0 (0.0)
TNF-/ 3.2b (1.3b) 0.0 (0.0) 2.7 (3.0b) 1.7 (2.0b) 0.0 (0.0) 0.1 (0.0) 1.0 (0.0) 0.0 (0.5) 0.0 (0.0)
IFN-/ 1.5b (1.3b) 1.1b (1.8b) 3.3b (3.5b) 2.3 (2.0) 0.0 (0.0) 0.1 (0.0) 0.0b (0.0) 0.0 (0.0) 0.0 (0.0)
wt (B6) 0.4 (0.0) 0.1 (0.0) 2.0 (1.0) 2.3 (1.0) 0.3 (0.0) 0.0 (0.0) 1.0 (0.0) 0.0 (0.0) 0.0 (0.0)
a 0, none; 1, mild; 2, moderate; 3, marked; 4, severe. High-dose NM I infection of SCIDbg, SCID, and wt (CB17) mice was not performed.
b P  0.05 for a comparison with the wt group with the same infection.
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response. The antigen distribution in IFN-/ mice was dif-
fuse, and antigen did not accumulate in perivascular or peri-
portal regions or in cellular accumulations in the lungs, livers,
and spleens (Fig. 8). Nude mice had mild to moderate, random
to perivascular inflammation in the liver and scattered necrotic
hepatocytes (Fig. 8H, I, R, S, and V). muMT and bg mice had
cellular inflammation in all organs (Fig. 8K and T). However,
C. burnetii antigen was not detected in muMT mice (Fig. 8N).
TNF-/ mice had the most severe inflammation score for
the heart, in which cellular infiltration was found in the endo-
cardium and epicardium and was diffuse in the myocardium
(Fig. 8C). The inflammation scores of wt mice were mild for
the heart and lung (Fig. 8A and 8B) and marked for the liver
and spleen (Fig. 8J and U). Immunodeficient mice infected
with NM II showed histopathologic changes in the lungs and
livers (Table 3). The spleens had slight to mild EMH, and lung
inflammation was seen principally in alveolar walls containing
macrophages. In nude mice, the lungs had thickened alveolar
walls containing macrophages; the livers contained mild ran-
dom and perivascular accumulations of macrophages and scat-
tered small foci of hepatocellular necrosis; and the spleens
had mild excess macrophages. In muMT mice, the livers had
multifocal accumulations of inflammatory cells with scattered
hepatocellular necrosis. bg mice had scattered minor foci of
inflammatory cell accumulations, which were sometimes asso-
ciated with vasculature, and occasional single hepatocytic ne-
crosis in the liver. TNF-/ mice had mild foci of inflamma-
tory cell accumulations in the liver. wt mice had scattered
minor foci of inflammatory cell accumulations with occasional
necrosis of single hepatocytes. C. burnetii antigen in NM II-
infected animals was barely detected (Table 3). No specific
histopathological change or C. burnetii antigen was found in
PBS groups (Fig. 8D and Q), except for occasional EMH in the
liver or spleen.
DISCUSSION
In both NM I and NM II infections, T cells have a critical
role in the clearance of the bacterium, and B cells have an
important role in protecting against tissue damage. IFN- and
TNF- have a key role in the early stage of the infection, and
IFN- expression is essential for effective clearance and sur-
vival in NM I-challenged animals. Several studies have dem-
onstrated that immunosuppressed or immunodeficient mice,
such as cyclophosphamide-treated mice, nude mice, SCID
mice, and SCIDbg mice, have dramatically heightened sensi-
tivity to C. burnetii infection (2, 3, 9, 17, 25, 26). Our results
provide the first evidence demonstrating that T cells and IFN-
are essential immune components for controlling the infection.
Three mouse strains with T-cell deficiency showed persistent
clinical disease with large bacterial loads in the spleen, sug-
gesting a major role for T cells in C. burnetii clearance. This
hypothesis is supported by an in vitro study showing that T
lymphocytes are the major contributor to the immune response
FIG. 5. Liver histopathology of mice infected with the high dose of NM II at 28 DPI. (A) SCIDbg mice had hepatocellular coagulative necrosis
(arrowhead) and severe cellular accumulation (arrows). (B) SCID mice had granuloma-like cellular accumulation (arrows). (C) wt (CB17) mice
had mild cellular coagulation (arrow). HE staining was used. Original magnification, 	100.
FIG. 6. Body weight changes of mice infected with the high dose of NM I or NM II. (A) Nude mice; (B) IFN-/ mice. The double dagger
indicates that the data for IFN-/ mice infected with the high dose of NM I at 14, 21, and 28 DPI are from a single mouse that survived (three
of four mice died before 14 DPI). The results (means  standard deviations) are expressed as the body weight index. An asterisk indicates that
the P value is 0.05 for comparisons of infected mice with PBS-inoculated control mice.
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to C. burnetii, as measured by their lymphoproliferative re-
sponse (22).
Splenomegaly has been routinely used as an indicator of C.
burnetii infection in experimental animals. In wt mice, the
degree of splenomegaly is correlated with the bacterial load in
the spleen (41). Splenomegaly is only a correlate of bacterial
colonization and is not highly sensitive for discriminating dif-
ferences between mouse strains. Detection of bacterial antigen
using immunohistochemistry is useful to localize bacteria, but
it is not suitable to evaluate numbers of bacteria because of low
sensitivity. Quantification of viable bacteria by tissue culture
infection is time-consuming and has a low sensitivity. There-
fore, we believe that detection of bacterial genome copies is
the optimal tool for the evaluation of infection.
The high mortality rate and short survival time of IFN-/
mice infected with NM I suggests that the mice failed to con-
trol replication of NM I early in the infection. In vitro studies
have shown that IFN- restored impairment of phagosome
maturation of macrophages infected with C. burnetii (16) and
,
FIG. 7. Spleens of mice infected with the high dose of NM I or NM II: splenomegaly (A) and bacterial genome numbers (B) in the spleen at 28 DPI. The
results (means standard deviations) are expressed as the percentage of spleen weight based on the body weight (A) and the number of C. burnetii genomes
in the whole spleen (B). One asterisk indicates that the P value is0.05 and two asterisks indicate that the P value is0.001 for the comparison of infected mice
with wt mice infected with the same inoculum. (A) Every mouse group infected with NM I had significant differences from the control group of the same mouse
strain treated with PBS (P  0.05 for wt [B6], muMT, and bg mice; P  0.001 for nude and TNF-/ mice). Double dagger, not detected.
TABLE 4. Bacteremia and mortality in single-immune-component-
deficient mice infected with the high dose of NM I
Mice
No. with bacteremia/total no. No. that died/
total no.7 DPI 14 DPI 21 DPI 28 DPI
Nude 0/4 2/4 4/4 4/4 0/4
muMT 0/4 0/4 0/4 0/4 0/4
bg 0/4 0/4 0/4 0/4 0/4
TNF-/ 3/3 0/3 0/3 1/3 0/3
IFN-/ 4/4 1/1 1/1 1/1 3/4
wt (B6) 0/4 0/4 0/4 0/4 0/4
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promoted apoptosis of the infected cells (12), resulting in C.
burnetii killing. IFN--mediated control of NM I has been
reported in mouse cells (J774 and peritoneal macrophages) (6)
and also in human cells (THP-1 and peripheral blood mono-
nuclear cells) (16). These reports support the conclusions in
this study that IFN- is crucial for the innate immune response
to NM I infection. IFN- has also been shown to be important
for the control of NM II infection in vitro (40); however, we did
not detect this requirement in our study, suggesting that NM II
replication could be controlled in vivo without IFN-. The
distribution of antigen in the tissues of IFN-/ mice infected
with NM I was diffuse and different from that in other mice,
where antigens were more likely to be distributed in peri-
vascular areas. IFN- increases expression of cell adhesion
molecules on immune cells and functions to increase their
extravasation from vascular sites to inflammatory areas (21).
Deficiencies in inflammatory cell recruitment and a lack of a
defined circumscript quality of granulomas in IFN-/ mice
have been reported in Mycobacterium avium infection (18).
The diffuse antigen distribution seen in IFN-/ mice in-
fected with NM I could be due to a lack of proper cellular
recruitment. Therefore, the early death of IFN-/ mice can
be explained by the lack of macrophage bactericidal activation
and cell migration to the site of inflammation.
TNF- deficiency increased the bacterial load in NM I-in-
fected mice. TNF- partially mediates IFN--dependent kill-
ing of C. burnetii and cell death (11). Bacteremia was seen in all
TNF-/ mice at the earliest time point but only in a single
mouse at later time points. We speculate that this was due to
an early failure of macrophage activation that can be rescued
when significant acquired cell-mediated immunity is devel-
oped. TNF-/ mice infected with NM I had the most severe
heart lesions. TNF- is known to upregulate expression of
adhesion receptors, including intercellular adhesion molecule
1 in cardiomyocytes and V- and P-selectin and vascular cell
adhesion molecule 1 in endothelial cells that mediate efficient
binding of circulating leukocytes (10, 14). We speculate that
the severe lesions found in TNF-/ mice were due to the
combination of bacteremia and a lack of efficient leukocyte
recruitment. The influence of tissue-specific macrophages was
apparent in the heart, an organ that normally lacks resident
macrophages. The results for IFN-/ and TNF-/ mice
suggest the importance of macrophage activation at early times
postinfection and immune cell recruitment to the site of
infection.
B-cell deficiency did not affect bacterial clearance but did
alter histopathology. This provides evidence that supports the
hypothesis that B cells play an important role in regulation of
inflammation against C. burnetii infection. A direct comparison
of SCID and nude mice with NM I infections showed similar
clinical signs in both mouse strains, such as loss of activity,
cachexia, and body weight loss, but longer survival times in
nude mice (M. Andoh, G. Zhang, and K. Hirai, unpublished
data), which supports a role for B cells in resistance against the
infection. B cells have been reported to produce interleukin-
10, which is an important negative regulator of cell-mediated
immunity that inhibits IFN- secretion from activated Th1 and
NK cells (13, 37). For many bacterial pathogens, Th1 cells are
important in the activation of macrophages, and activated mac-
rophages are critical for the clearance of pathogens. However,
without careful regulation of this inflammatory response, self-
damage of host tissues can occur, as seen in chronic infection
with the intracellular bacterium Chlamydia trachomatis (5).
Our recent findings demonstrate that heat-killed NM I induces
a strong Th1 response, while heat-killed NM II induces a weak
Th1 response (G. Zhang, K. E. Russell-Lodrigue, M. Andoh,
Y. Zhang, L. R. Hendrix, and J. E. Samuel, submitted for
publication). We speculate that the severe histopathologic
changes with successful bacterial clearance in muMT mice are
due to the inability to downregulate a Th1 response associated
with B-cell deficiency. Therefore, our results support a model
whereby T-cell activity is critical for the clearance of bacteria
and B-cell activity supports the successful control of pathology.
The role of NK cells in C. burnetii infection was not clearly
identified in this study. Although histopathology was more
severe in SCIDbg mice than SCID mice, the numbers of bac-
teria in these mice were similar. There was no notable differ-
ence between bg and wt mouse infections. Although the bg
mutant mouse has abnormalities in all granule-containing cells,
including lymphocytes, the most notable defect is in NK cell
function (31). We believe that NK cells have an accessory role
in the inflammatory response but are not crucial for prevention
of bacterial replication. They may provide an immediate supply
of IFN- for the activation of macrophages in the innate im-
mune response (36).
The three T-cell-deficient mouse strains allowed NM II to
establish an infection; the histopathologic changes in several
organs demonstrated this ability to cause systemic infections in
immunodeficient animals. Although the bacterial load and an-
tigen distribution in NM II-infected mice were limited and
TABLE 5. C. burnetii phase I and II specific IgG titers of mice at 28 DPI detected by theindirect immunofluorescence assay
Mice
NM I infection NM II infection
Anti-phase I titer Anti-phase II titer Anti-phase I titer Anti-phase II titer
Mean Range Mean Range Mean Range Mean Range
Nude NTa NT NT 40 32–64
muMT NT NT NT NT
bg 512 256–1,024 2,048 2,048 38 32–64 1,024 1,024
TNF-/ 406 256–512 2,048 2,048 27 16–32 609 256–2,048
IFN-/ 128b 2,048b 64 64 1,024 1,024
wt (B6) 724 512–1,024 2,048 2,048 45 32–64 724 512–1,024
a NT, not detectable.
b Value for a single serum from a surviving mouse.
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FIG. 8. Histopathology of mice infected with the high dose of NM I at 28 DPI. (A to C) Heart; (D to I) lung; (J to P) liver; and (Q to X) spleen.
(D and Q) Tissue section of PBS group. (A to C, J to L, and Q to U) HE staining; (D to I, M to P, and V to X) IHC staining. (A to E, G, H,
J to L, O, Q to W) Original magnification, 	100; (M and N) original magnification, 	200; (F, I, P, and X) original magnification, 	400. (A and
B) Hearts of wt mice had few small areas of cellular coagulation in the myocardium (arrowhead). (C) Hearts of TNF-/ mice had extensive
cellular infiltration in the myocardium. (D) C. burnetii antigen was not detectable in PBS groups, and there was no nonspecific IHC staining. (E
and F) Lungs of IFN-/ mice had C. burnetii antigen distributed in the parenchyma and not accumulated in perivascular areas. (G and M) C.
burnetii antigen in wt mice was barely detectable. (H and I) Lungs of nude mice had abundant antigen distributed primarily in perivascular areas.
(J and M) Livers of wt mice had perivascular, periportal, and random formation of small cellular accumulations (arrowheads) but no detectable
C. burnetii antigen. (K and N) Livers of muMT mice had perivascular, periportal, and random cellular accumulation but no detectable C. burnetii
antigen. (L, O, and P) Livers of IFN-/ mice had diffuse cellular infiltration and antigen distribution. (Q) Spleens of nude mice had smaller
follicles than wt mice but no characteristic pathological changes. (R and V) Spleens of nude mice had diffuse cellular infiltration and antigen
distribution that obscured tissue architecture. (S, W, and X) Spleens of IFN-/ mice had random cellular accumulations and scattered C. burnetii
antigen distribution. (T) Spleens of muMT mice had marked random cellular accumulations (arrowheads).
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clinical signs of disease were never observed, this is the first
report of NM II colonization in vivo. In SCID and SCIDbg
mice infected with NM II, pathological changes were dose
dependent, but the bacterial loads were similar. In a guinea pig
model, high infectious doses of NM II caused a short-term
fever response, but organisms were not detected in the infected
animals (28). These observations suggest that NM II infection
can be partially controlled by innate immunity; however, ac-
quired cell-mediated immunity is required for bacterial clear-
ance. Capo et al. reported in vitro data showing that NM II is
ingested more effectively than NM I and fails to survive within
macrophages (8). However, in vivo without T-cell-mediated
immunity, NM II could remain in the organs for 4 weeks. We
speculate that the difference between NM I and NM II in the
interaction with receptors and trafficking to different intracel-
lular compartments (8) is not the primary cause of the differ-
ence in bacterial killing and elimination in vivo.
Nude mice infected with NM II allowed the bacteria to
colonize and developed detectable antibody, but the titers were
lower than those in other NM II-infected mice. The low anti-
body titer in spite of bacterial colonization could be explained
by the fact that nude mice have an impairment in antibody
production due to a lack of helper T cells and a partial defect
in B-cell maturation (23). Alternatively, nude mice infected
with NM I did not have detectable antibody even though their
bacterial load was greatest and clinical signs were the most
severe of all the single-immune-component-deficient mice,
while other mice infected with NM I had high antibody titers
with a smaller bacterial load. In addition to the impairment in
nude mice noted above, we believe that there could be two
possible explanations for the total lack of antibody to NM I;
one explanation is immunosuppresion caused by NM I, re-
ported as a lymphocyte hyporesponsiveness (38). Recently, we
observed a hyporesponsiveness to specific recall antigen and
mitogens by splenocytes during acute infection in both mice
and guinea pigs (G. Zhang, unpublished data; K. E. Russell-
Lodrigue, unpublished data). The other explanation may be
the difference in the responses of dendritic cells (DCs) be-
tween NM I and NM II infections. Recent in vitro data have
shown that NM I did not activate DC, while NM II infection
led to upregulation of major histocompatibility complex class
II and CD40 expression as measures of DC maturation (35).
DCs use major histocompatibility complex class II and CD40
to contact and activate B cells (39). In nude mice infected with
NM I, B cells likely do not get activated by DCs and lack helper
T cells, resulting in no detectable antibody production.
Our study demonstrated the in vivo roles of various immune
system components in the control of C. burnetii infection in
mice. Each immune component has previously been studied
independently, but the components have never been compared
directly in an animal model. Comparison of NM I and NM II
infections showed that acquired immunity is essential to over-
come both infections, and NM I may be able to escape innate
immune mechanisms that are designed to control bacterial
replication. These observations provide a better understanding
of the virulence of C. burnetii and Q fever pathology.
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